Managing hypoglycaemia risk in non-diabetic CKD patients

Why GLP-1s rarely cause low blood sugar in non-diabetics, and what to watch for if you have kidney failure.

Written by Professor Mohammed Mahdi Althaf

Overview

GLP-1 medications are glucose-dependent, meaning they only stimulate insulin when sugar is high. However, in advanced CKD, medication clearance is slower, and risk profiles change.

This article is general information and is not individual medical advice. Treatment decisions are made at a face-to-face consultation.

More in Side effects, safety and contraindications

Book your first consultation